About Ossio
Ossio is a company based in Caesarea (Israel) founded in 2014 by Orahn Preiss Bloom. Ossio has raised $89.01 million across 5 funding rounds from investors including MVM Partners, Questa Capital and OCV Partners. Ossio offers products and services including Suture Anchors, Compression Staple, Compression Screws, Trimmable Fixation Nails, and Threaded Trimmable Fixation Nails. Ossio operates in a competitive market with competitors including Biocomposites, CartiHeal, Theradaptive, MiMedx Group and RevBio, among others.
- Headquarter Caesarea, Israel
- Founders Orahn Preiss Bloom
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ossio Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$89.01 M (USD)
in 5 rounds
-
Latest Funding Round
$50 M (USD), Debt – Conventional
Feb 12, 2026
-
Investors
MVM Partners
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ossio
Ossio offers a comprehensive portfolio of products and services, including Suture Anchors, Compression Staple, Compression Screws, Trimmable Fixation Nails, and Threaded Trimmable Fixation Nails.
Devices for securing sutures in bone fixation procedures.
Tool for compressing bones to aid healing processes.
Screws used for stabilizing fractures during recovery.
Nails that provide adjustable support for bone alignment.
Threaded nails for enhanced fixation in orthopedic repairs.
System for correcting and fixing hammertoe deformities.
People of Ossio
Unlock access to complete
Funding Insights of Ossio
Ossio has successfully raised a total of $89.01M across 5 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $50 million completed in February 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Ossio
Ossio has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include MVM Partners, Questa Capital and OCV Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth-stage VC and PE investments are directed across multiple sectors.
|
Locked | Locked | Locked | |
|
Private equity investments in healthcare companies are managed.
|
Locked | Locked | Locked | |
|
Venture capital investments are provided by OCV Partners.
|
Locked | Locked | Locked |
Investor details for Ossio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ossio
Investment portfolio details for Ossio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ossio
Detailed financials for Ossio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ossio Comparisons
Peer comparison for Ossio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ossio
Ossio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biocomposites, CartiHeal, Theradaptive, MiMedx Group and RevBio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Synthetic calcium composites are developed for bone repair and regeneration.
|
|
| Locked | Locked | Locked |
Implants for bone and cartilage regeneration are developed and provided.
|
|
| Locked | Locked | Locked |
Therapeutic delivery platform is developed for orthopedic clinical indications.
|
|
| Locked | Locked | Locked |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
|
| Locked | Locked | Locked |
Synthetic adhesives for bone and dental repair are developed.
|
Detailed competitors of Ossio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ossio
Complete news archive for Ossio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ossio
Ossio was founded in 2014 and raised its 1st funding round 4 years after it was founded.
Ossio is headquartered in Caesarea, Israel. It is registered at Caesarea, Haifa, Israel.
Brian Verrier is the current CEO of Ossio.
Ossio is a funded company, having raised a total of $89.01M across 5 funding rounds to date.
Ossio was founded in 2014 in Caesarea, Israel, within the biotechnology sector focused on orthopedics. Operations center on the development of OSSIOfiber, a biocomposite platform integrating synthetic bone fibers for mechanical reinforcement with bioabsorbable polymer resin for binding and bone growth promotion. This technology supports fixation devices that gradually resorb, aiding natural bone regeneration in clinical applications.
Ossio's top competitors include EpiBone, Theradaptive and MiMedx Group.
Ossio offers Suture Anchors, Compression Staple, Compression Screws, Trimmable Fixation Nails, and 2 more products and services.
Ossio has 8 investors. Key investors include MVM Partners, Questa Capital, OCV Partners, Courage Capital Management, and OrthoVision.